BCL11B and acute lymphoblastic leukemia: scNOVA discovered downregulation of BCL11B, a known haploinsufficient T-ALL tumor suppressor57, as a significant local effect of this balanced inversion, supporting allele-specific silencing of BCL11B on the rearranged haplotype as measured by RNA-seq24 (Extended Data Fig. 6).